day 1 agenda
|
Scientific Program |
||
|
Day -1: July (06, 2026) |
||
|
Meeting Hall - PARIOLI 1 |
||
|
Registrations Open (08:30-09:10) |
||
|
Opening Ceremony (09:10-09:30) |
||
|
Keynote Talks |
||
|
Ted Rothstein, George Washington University, United States |
09:30-10:00 |
Title: Neuroanatomic changes associated with 55 consecutive long-term post COVID-19 patients with cognitive deficits |
|
|
|
|
|
Bram Palache, Flupal Consultancy, Netherlands |
10:00-10:30 |
Title: Disparities in Seasonal Influenza Vaccination in Europe |
|
|
|
|
|
Airi Poder, |
10:30-11:00 |
Title: Recruitment Strategies for Vaccine Trials in Areas of Low Population Density |
|
|
|
|
|
Group Photo & Refreshment Break (11:00-11:20) |
||
|
Scientific Session I |
||
|
|
|
|
|
Moriya Tsuji, Columbia University, United States |
11:20-11:40 |
Title: Harnessing CD1d-restricted NKT cells to prevent respiratory viral infections in vivo |
|
|
|
|
|
Rene Traksel, Maxima Medical Center, Netherlands |
11:40-12:00 |
Title: Oral iodine in COVID-19 patients: effects on clinical outcomes and antiviral immune responses |
|
|
|
|
|
Manish A Mahajan, Zydus Lifesciences, India |
12:00-12:20 |
Title: Adaptive Clinical Trial Designs in Lower Middle Income Countries: Role Beyond Pandemic Preparedness |
|
|
|
|
|
Arlene Calvo, University of South Florida, United States |
12:20-12:40 |
Title: Follow-up of HPV Vaccine Outcomes in Panama |
|
|
|
|
|
Jürgen Gailer, University of Calgaray, Canada |
12:40-13:00 |
Title: Degradation of the Vaccine Additive Thimerosal by L-Glutathione and L-Cysteine at Physiological pH |
|
|
|
|
|
(13:00-14:00) Lunch Break @ Restaurant |
||
|
Scientific Session II |
||
|
|
|
|
|
Mya Myat Ngwe Tun, Nagasaki University, Japan |
14:00-14:20 |
Title: A Multicounty assessment of Chikungunya Virus Infection in Asia Using Molecular and Serological Approaches |
|
|
|
|
|
Thomas P Monath, Quigley Biopharma, USA |
14:20-14:40 |
Title: PHV02 Live, attenuated recombinant VSV vaccine against Nipah Virus: Clinical trial update |
|
|
|
|
|
Adam Frederik Sander, University of Copenhagen, Denmark
|
14:40-15:00 |
Title: Combining mRNA Speed with cVLP immunogenicity - A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles |
|
|
|
|
|
Albert Jonathan Auguste, Virginia Tech, United States |
15:00-15:20 |
Title: Exploring the immunogenicity and efficacy of an insect virus-based vaccine against Zika virus and Spondweni virus |
|
|
|
|
|
Ademola O. Olaniran, University of KwaZulu-Natal, South Africa |
15:20-15:40 |
Title: Rotaviruses in treated wastewater effluent and receiving aquatic milieu: Prevalence, Genetic characterization and Infectivity |
|
|
|
|
|
Rajendra Upadhya, Duke University, USA |
15:40-16:00 |
Title: Targeting Fungal Cell Wall Biology to Develop Whole-Cell Vaccines Against Cryptococcosis |
|
Refreshment Break(16:00-16:10) |
||
|
|
|
|
|
Sam Pallerla, IAVI, USA |
16:10-16:30 |
Title: Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoparticles (SMNP) |
|
|
|
|
|
Ying Peng, Zhengzhou University, China |
16:30-16:50 |
Title: A cDC1 targeting, plug-and-play custom nanoparticle vaccine triggers effective cancer immunity
|
|
|
|
|
|
Bella Manshion, KU Leuven, Belgium |
16:50-17:10 |
Title: Combination therapy of inorganic nanocparticles with Anti-PD1 reduces tumor growth and acts as targeted selective anti-tumor therapy |
|
|
|
|
|
Pannel Discussions |
||
|
End of Day-1 |
||
day 2 agenda
|
Scientific Program |
||
|
Day -2: June (07, 2026) |
||
|
Meeting Hall - PARIOLI 1 |
||
|
Scientific Session III |
||
|
|
|
|
|
Kai-Michael Toellner, Babraham Institue, United Kingdom |
10:20-10:40 |
Title: Mastering Immunity: Antibody Feedback as a Driver of Germinal Centre Fate and Vaccine Responses
|
|
Sara Landeras, University CEU Spain |
10:40-11:00 |
Title: Antigenic landscape and structural stabilization of the SARS-CoV-2 Nucleocapsid protein |
|
Roberto Ademo, GlaxoSmithkile Italy |
11:00-11:20 |
Title: Towards a polysaccharide-based Group B Streptococcus vaccinefor Global Health
|
|
Antonio Acosta-Hoyos, Universidad Simon Bolivar, Colombia
|
11:20-11:40 |
Title: Point of care dengue screening & Verima stratification by raman spectroscopy of serum liquid biopsies
|
|
|
|
|
|
Sara Al Dahir, Xavier University of Louisiana, USA |
11:40-12:00 |
Title: The Impact of Coronavirus Pandemic Shutdowns on Immunization Completion in Hadeetha, Anbar, Iraq: A Case-Study of Vaccine Completion in a Recovering Healthcare System |
|
|
|
|
|
Cristina Scavone, Link University, Italy |
12:00-12:20 |
Title: Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies |
|
|
|
|
|
Clint McDaniel, UMass Chan Medical School,USA |
12:20-12:40 |
Title: Cryo-electron tomography reveals virion-associated influenza hemagglutinin clusters upon receptor binding |
|
|
|
|
|
Sung-Hou Kim, University of California, United States |
12:40-13:00 |
Title: Whole-genome demography of COVID-19 virus during its pandemic period and On a pan- valent vaccine design and test in mice |
|
|
|
|
|
(13:00-14:00) Lunch Break @ Restaurant |
||
|
Poster presentations (14:00-15:00) |
||
|
Scientific Session IV |
||
|
|
|
|
|
|
|
|
|
Slot Available |
15:00-15:20 |
TBD
|
|
|
|
|
|
Andrea Malaspina, University College London, United Kingdom |
15:20-15:40 |
Title: Neurofilament and Dipeptide Repeats Autoantibodies and Loss of Immune Tolerance in Amyotrophic Lateral Sclerosis
|
|
|
|
|
|
Slot Available |
15:40-16:00 |
TBD
|
|
|
|
|
|
Refreshment Break(16:00-16:10) |
||
|
|
|
|
|
Slot Available |
16:10-16:30 |
TBD
|
|
|
|
|
|
Stine Søgaard Normann, University of Southern Denmark, Copenhagen |
16:30-16:50 |
Title: Prenatal and childhood PFAS exposure and vaccine?induced immunity at 15 years of age in a Faroe mother?child cohort |
|
|
|
|
|
Gisselle Nilda Medina, USDA, United States |
16:50-17:10 |
Title: Rethinking next-generation FMDV vaccines: use of codon deoptimization strategies |
|
Closing Ceremony |
||
|
Please note that this program is tentative, and the timings are subjected to change |
||
|
If any one interested to attend the conference or to book your speaker slot, please send an email to ryan_cooper@vaccine-congress.org |
||